Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. Haloperidol

International Clinical Psychopharmacology

Volumn 7, Issue 1, 1992, Pages 23-27

  Barnas, C ^a   Stuppack C H ^a   Miller, C ^a   Haring, C ^a   Sperner Unterweger, B ^a   Fleischhacker, W W ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; ZOTEPINE;

ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSTONIA; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RIGOR; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREMOR; XEROSTOMIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DIBENZOTHIEPINS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0026699928     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199200710-00003     Document Type: Article

References (31)

1. Amamoto H (1980) Clinical use of zotepine. Clinical Reports, 14, 292.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn, Revised (DSM-III-R). APA, Washington, DC.
3. Angrist B, Rotrosen J and Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72, 17-19.
4. Arikawa K, Yamauchi I, Mukasa H, Ishibashi A, Matsuoka M and Miura T (1980) Clinical experience with zotepine in schizophrenia. Japanese Journal of Clinical Psychiatry, 9, 101.
5. Barnas C, Stuppack CH, Unterweger B, Hinterhuber H and Fleishhacker WW (1987) Treatment of negative symptoms in schizophrenia with zotepine. Journal of Clinical Psychopharmacology, 7, 370-371.
6. Cesarec Z and Nymann AK (1985) Differential response to amphetamine in schizophrenia. Acta Psychiatrica Scandinavica, 71, 523-538.
7. Ceulemans DLS, Gelders YG, Hoppenbrouwers ML, Reyntijens AJM and Janssen PAJ (1985) Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone. Psychopharmacology, 85, 329.
8. Csemansky JG, Brown K and Hollister LE (1986) Is there drug treatment for negative schizophrenic symptoms? Hospital Formal, 21, 790-792.
9. Dieterle DM, Albus MI, Eben E, Ackenheil M and Rockstroh W (1986) Preliminary experiences and results with the Munich version of the Andreasen scale. Pharmacopsychiatry 19, 96-100.
10. Dieterle D, Müller-Spahn F and Ackenheil M (1991) Wirksam-keit und Verträglichkeit von Zotepin im Doppelblindver-gleich mit Perazin bei schizophrenen Patienten. Fortschritte Der Neurologie-Psychiatrie, 1, 18-23.
11. Fleischhacker WW, Barnas C, Stuppäck CH, Unterweger B and Hinterhuber H (1987) Zotepine in the treatment of negative symptoms in chronic schizophrenia. Pharmacopsychiatry, 20, 58-60.
12. Fleischhacker WW, Bamas C, Stuppäck CH, Unterweger B, Miller C and Hinterhuber H (1989) Zotepine vs. haloperidol in paranoid schizophrenia: a double blind trial. Psychopharmacology Bulletin, 25, 97-100.
13. Frangos H, Zissis NP, Leontopoulos I, etal. (1978) Double-blind therapeutic evaluation of fluspirilene with fluphenazine decanoate in chronic schizophrenics. Acta Psychiatrica Scandinavica, 57, 436-446.
14. Haas S and Beckmann H (1982) Pimozide versus haloperidol in acute schizophrenia. A double blind controlled study. Pharmacopsychiatry, 15, 70-74.
15. Kane JM, Rifkin A, Woemer M and Reardon G (1982) Low dose neuroleptics in outpatient schizophrenics. Psychopharmacologv Bulletin, 18, 20-21.
16. Kane J, Honigfeld G, Singer J and Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
17. Kane J and Mayerhoff D (1989) Do negative symptoms respond to pharmacological treatment? British Journal of Psychiatry. 155, 115-118.
18. Keith SJ, Starr S and Matthews SM (1984) A team approach to pharmacologic treatment of chronic schizophrenia. Hospital and Community Psychiatry, 35, 802-805.
19. Klieser E, Lehmann E and Tegeler J (1991) Doppelblindvergleich won 3 X 75 mg Zotepin und 3 X 4mg Haloperidol bei akut schizophrenen Patienten. Fortschritte Der Neurnlogie-Psychiatrie, 1, 14-18.
20. Kolivakis T, Azian H and Kingstone E (1974) A double blind comparison of pimozide and chlorpromazine in the maintenance of chronic schizophrenic patients. Current Therapeutic Research, 16, 998-1004.
21. Lapierre YD (1978) A controlled study of penfluridol in the treatment of chronic schizophrenia. American Journal of Psychiatry, 135, 956-959.
22. Mackay AV (1985) New antipsychotic agents and the future. Journal of Clinical Psychiatry, 46, 51-53.
23. Müller-Spahn F, Dieterle D and Ackenheil M (1991) Klinische Wirksamkeit von Zotepin bei therapieresistenten Psychosen mit vorherrschender Minussymptomatik. Ergebnisse einer offenen und einer doppelblind-kontrollierten Studie. Fort-schritte Der Neurologie-Psychiatrie, 1, 30-46.
24. National Institute of Mental Health (1981a) Clinical Global Impressions (CGI). In: Collegium Internationale Psychiatriae Scalarum: Internationale, Skalen für Psychiatrie, Beltz Test, Weinheim.
25. National Institute of Mental Health (1981b) Dosage Record and Treatment Emergent Symptom Scale (DOTES). In: Collegium Internationale Psychiatriae Scalarum Internationale Skalen für Psychiatrie. Beltz Test, Weinheim.
26. Noda K, Suzuki A, Okui M, Noguchi H, Nishiura M and Nishiura N (1979) Pharmacokinetics and metabolism of 2-chIoro-ll-(2-dimethylaminomethoxy)-dibenzo[b, f]thiepine (zotepine) in rat. mouse, dog and man. Artneimittel Forsch/Drug Research, 29, 1595-1600.
27. Overall JE and Gorham DR (1981) Brief Psychiatric Rating Scale (BPRS). In: Collegium Internationale Psychiatriae Scalarum: Internationale Skalen für Psychiatric, Beltz Test, Weinheim.
28. Shimomura K, Satoh H, Hirai O, et al. (1982) The central antiserotonin activity of zotepine, a. new neuroleptic, in rats. Japanese Journal of Pharmacology, 32, 405-412.
29. Stahl SM and Wets K (1987) Indolamines and schizophrenia. In: Handbook of Schizophrenia, Vol. 2, Neurochemistry and Neu-ropharmacology of Schizophrenia (Eds FA Henn and LE DeLisi), pp. 257-296. Elsevier, Amsterdam.
30. Uchida S, Honda F, Otsuka M, et al. (1979) Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo [b, f] thiepine] (zotepine). a new neuroleptic drug. Arzneimittel Forsch./Drug Research, 29, 1588-1594.
31. 2) receptor function. Japanese Journal of Neuropsychopharmacology, 8, 315-322.